DekaBank Deutsche Girozentrale’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.48M | Hold |
100,000
| – | – | 0.01% | 589 |
|
|
2025
Q1 | $3.43M | Hold |
100,000
| – | – | 0.01% | 635 |
|
|
2024
Q4 | $2.73M | Hold |
100,000
| – | – | 0.01% | 694 |
|
|
2024
Q3 | $2.48M | Hold |
100,000
| – | – | ﹤0.01% | 714 |
|
|
2024
Q2 | $2.51M | Hold |
100,000
| – | – | ﹤0.01% | 713 |
|
|
2024
Q1 | $3.08M | Hold |
100,000
| – | – | 0.01% | 675 |
|
|
2023
Q4 | $4.15M | Hold |
100,000
| – | – | 0.01% | 621 |
|
|
2023
Q3 | $2.7M | Hold |
100,000
| – | – | 0.01% | 674 |
|
|
2023
Q2 | $1.7M | Hold |
100,000
| – | – | ﹤0.01% | 787 |
|
|
2023
Q1 | $1.71M | Buy |
100,000
+50,000
| +100% | +$854K | ﹤0.01% | 751 |
|
|
2022
Q4 | $373K | Hold |
50,000
| – | – | ﹤0.01% | 1104 |
|
|
2022
Q3 | $500K | Buy |
50,000
+10,200
| +26% | +$102K | ﹤0.01% | 1043 |
|
|
2022
Q2 | $344K | Hold |
39,800
| – | – | ﹤0.01% | 1090 |
|
|
2022
Q1 | $413K | Buy |
39,800
+3,600
| +10% | +$37.4K | ﹤0.01% | 1095 |
|
|
2021
Q4 | $517K | Buy |
36,200
+1,000
| +3% | +$14.3K | ﹤0.01% | 1089 |
|
|
2021
Q3 | $1.65M | Sell |
35,200
-18,000
| -34% | -$843K | ﹤0.01% | 768 |
|
|
2021
Q2 | $3.13M | Hold |
53,200
| – | – | 0.01% | 636 |
|
|
2021
Q1 | $3.09M | Buy |
53,200
+15,000
| +39% | +$871K | 0.01% | 598 |
|
|
2020
Q4 | $2.55M | Sell |
38,200
-1,900
| -5% | -$127K | 0.01% | 612 |
|
|
2020
Q3 | $1.45M | Buy |
+40,100
| New | +$1.45M | 0.01% | 665 |
|